Related Experiment Video

Updated: May 19, 2026

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
09:05

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis

Yoshito Hayashi1, Masahiko Tsujii, Jun Wang

  • 1Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Gut
|September 1, 2012
PubMed
Abstract

Insights

Helicobacter pylori CagA protein disrupts let-7 microRNA expression through epigenetic silencing. This leads to Ras pathway activation, promoting gastric cancer development.

Area of Science:

  • Oncology
  • Microbiology
  • Epigenetics

Background:

  • MicroRNAs (miRNAs) are key regulators in carcinogenesis, acting as tumor suppressors or oncogenes.
  • Altered miRNA expression is linked to Helicobacter pylori (H pylori)-associated gastritis and gastric cancer.
  • The H pylori cytotoxin-associated gene A (CagA) plays a significant role in gastric carcinogenesis.

Purpose of the Study:

  • To investigate the impact of CagA on miRNA expression.
  • To elucidate the regulatory mechanisms underlying CagA-mediated miRNA dysregulation.

Main Methods:

  • Comprehensive miRNA microarray analysis to assess CagA's effect on miRNA expression.
  • In vitro and in vivo studies to examine CagA's influence on histone modification and DNA methylation.
  • Investigation of CagA-dysregulated signal transduction pathways involving let-7 miRNA.

Main Results:

  • CagA significantly reduced let-7 expression in vitro, activating the Ras pathway.
  • CagA increased c-myc, DNMT3B, and EZH2 expression while decreasing miR-26a and miR-101.
  • Epigenetic modifications (histone and DNA methylation) mediated CagA's attenuation of let-7 expression.
  • CagA transgenic mice showed elevated c-myc, EZH2, DNMT3B, and reduced let-7 expression, inducing Ras oncoprotein without inflammation.

Conclusions:

  • H pylori CagA protein induces aberrant epigenetic silencing of let-7 miRNA.
  • This epigenetic silencing leads to the upregulation of the Ras pathway, contributing to gastric carcinogenesis.
Keywords:
Gastric CancerHelicobacter PyloriMethylation

More Related Videos

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

Mouse Models Of Helicobacter Infection And Gastric Pathologies07:43

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Published on: October 18, 2018

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.